Kelvin Hong
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 40
- Liver Disease and Transplantation 9
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 13
-
- Renal cell carcinoma treatment 14
- Gallbladder and Bile Duct Disorders 7
-
- MRI in cancer diagnosis 11
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
-
- Liver Disease Diagnosis and Treatment 13
- Co-authors
- Christos GeorgiadesJean-François H. GeschwindEleni LiapiMichael TorbensonIhab R. KamelAfsheen KhwajaLuke HigginsJosephina A. Vossen
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Kelvin Hong
103 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 124
- Hepatology 1.2k
- Internal Medicine 220
- Pulmonary and Respiratory Medicine 1.0k
- Radiology, Nuclear Medicine and Imaging 472
- Surgery 867
Countries citing papers authored by Kelvin Hong
This map shows the geographic impact of Kelvin Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelvin Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelvin Hong more than expected).
Fields of papers citing papers by Kelvin Hong
This network shows the impact of papers produced by Kelvin Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelvin Hong. The network helps show where Kelvin Hong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kelvin Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 2 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 31 | |
| 9 | 2020 | 1 | |
| 10 | 2017 | 12 | |
| 11 | 2010 | 39 | |
| 12 | 2010 | 175 | |
| 13 | 2009 | 7 | |
| 14 | 2008 | 19 | |
| 15 | 2008 | 60 | |
| 16 | 2008 | 18 | |
| 17 | 2008 | 111 | |
| 18 | 2006 | 14 | |
| 19 | 2006 | 48 | |
| 20 | 2005 | 142 |
About Kelvin Hong
Kelvin Hong is a scholar working on Hepatology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 109 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (40 papers), Renal cell carcinoma treatment (14 papers), Venous Thromboembolism Diagnosis and Management (13 papers), Liver Disease Diagnosis and Treatment (13 papers), MRI in cancer diagnosis (11 papers), Liver Disease and Transplantation (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Gallbladder and Bile Duct Disorders (7 papers). The work is most often cited by research in Hepatology (1.2k citations), Internal Medicine (220 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Kelvin Hong has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Christos Georgiades, Jean-François H. Geschwind, Eleni Liapi, Michael Torbenson, Ihab R. Kamel, Afsheen Khwaja, Luke Higgins, Josephina A. Vossen, Manon Buijs and Hyun S. Kim. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.